Sophie Béliard

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Low Density Lipoprotein

Cardiovascular Risk Factors

Top Venues

Arteriosclerosis, thrombosis, and vascular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Sophie Béliard, Florian Mourre, René Valéro
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Diabetologia 67 (6) (2024)
Sophie Béliard, Florian Mourre, René Valéro
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Diabetologia 67 (6) (2024)
Sophie Béliard, Florian Mourre, René Valéro
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Diabetologia (2024)
Sophie Béliard, Samir Saheb, Stéphanie Litzler-Renault, Alexandre Vimont, René Valéro, Éric Bruckert, Michel Farnier, Antonio Gallo
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology (2024)
Sophie Béliard, Samir Saheb, Stéphanie Litzler-Renault, Alexandre Vimont, René Valéro, Éric Bruckert, Michel Farnier, Antonio Gallo
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
Sophie Béliard, Florian Mourre, René Valéro
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Diabetologia 67 (6) (2024)
Sophie Béliard, Florian Mourre, René Valéro
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Diabetologia 67 (6) (2024)
Sophie Béliard, Samir Saheb, Stéphanie Litzler-Renault, Alexandre Vimont, René Valéro, Éric Bruckert, Michel Farnier, Antonio Gallo
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
Sophie Béliard, Florian Mourre, René Valéro
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Diabetologia 67 (6) (2024)
Martine Paquette, Bertrand Cariou, Sophie Bernard, Robert A Hegele, Antonio Gallo, Jacques Genest, Mark Trinder, Liam R Brunham, Sophie Béliard, Alexis Baass
Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology (2023)